4 insiders reported 17 Form 4 transactions for RELMADA THERAPEUTICS, INC. (RLMD) over the past 18 months (most recent 2025-12-16). Recent activity: TRAVERSA SERGIO (Chief Executive Officer) Buy 27,500 shares, Shenouda Maged (Chief Financial Officer) Buy 11,665 shares, TRAVERSA SERGIO (Chief Executive Officer) Buy 272,500 shares, Ence Chuck (CAO and COO) Buy 136,000 shares, Shenouda Maged (Chief Financial Officer) Buy 500,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-16 | TRAVERSA SERGIO | Chief Executive Officer | Buy | 27,500 | $113,300 |
| 2025-12-16 | Shenouda Maged | Chief Financial Officer | Buy | 11,665 | $48,060 |
| 2025-11-06 | TRAVERSA SERGIO | Chief Executive Officer | Buy | 272,500 | $599,500 |
| 2025-11-06 | Ence Chuck | CAO and COO | Buy | 136,000 | $299,200 |
| 2025-11-06 | Shenouda Maged | Chief Financial Officer | Buy | 500,000 | $1.1M |
| 2025-11-06 | Kelly Paul Edward | Chief Operating Officer | Buy | 90,000 | $198,000 |
| 2025-08-28 | TRAVERSA SERGIO | Chief Executive Officer | Buy | 80,545 | $49,938 |
| 2025-08-28 | TRAVERSA SERGIO | Chief Executive Officer | Buy | 129,455 | $86,735 |
| 2025-08-28 | TRAVERSA SERGIO | Chief Executive Officer | Buy | 55,976 | $41,422 |
| 2025-05-20 | Ence Chuck | CA and CO | Buy | 228,961 | $103,032 |
| 2025-05-20 | Shenouda Maged | Chief Financial Officer | Buy | 50,000 | $22,000 |
| 2025-05-20 | Shenouda Maged | Chief Financial Officer | Buy | 90,000 | $44,100 |
| 2025-05-20 | Shenouda Maged | Chief Financial Officer | Buy | 60,000 | $31,200 |
| 2025-05-20 | Kelly Paul Edward | Chief Operating Officer | Buy | 200,000 | $86,000 |
| 2025-05-20 | TRAVERSA SERGIO | Chief Executive Officer | Buy | 172,314 | $77,541 |
| 2025-05-20 | TRAVERSA SERGIO | Chief Executive Officer | Buy | 30,000 | $15,000 |
| 2025-05-20 | TRAVERSA SERGIO | Chief Executive Officer | Buy | 147,686 | $82,704 |
Source: SEC Form 4 filings · as of 2025-12-16